Connection

Pragya Yadav to Humans

Back to Details
This is a "connection" page, showing publications Pragya Yadav has written about Humans.
Pragya Yadav
Connection Strength
0.164
Humans
  1. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.008
  2. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Viruses. 2021 05 17; 13(5).
    View in: PubMed
    Score: 0.008
  3. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India. Travel Med Infect Dis. 2021 May-Jun; 41:102023.
    View in: PubMed
    Score: 0.007
  4. Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage. J Travel Med. 2021 02 23; 28(2).
    View in: PubMed
    Score: 0.007
  5. Inactivation of SARS-CoV-2 by gamma irradiation. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):196-198.
    View in: PubMed
    Score: 0.007
  6. Full-genome sequences of the first two SARS-CoV-2 viruses from India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):200-209.
    View in: PubMed
    Score: 0.007
  7. Persistence of IgG antibodies in survivors of Crimean Congo hemorrhagic fever virus infection, India. J Infect Public Health. 2019 Jul - Aug; 12(4):598-599.
    View in: PubMed
    Score: 0.007
  8. Growth Kinetics of Kyasanur Forest Disease Virus in Mammalian Cell Lines and Development of Plaque Reduction Neutralization Test. Vector Borne Zoonotic Dis. 2019 08; 19(8):630-636.
    View in: PubMed
    Score: 0.007
  9. Detection of Kyasanur forest disease in newer areas of Sindhudurg district of Maharashtra State. Indian J Med Res. 2018 10; 148(4):453-455.
    View in: PubMed
    Score: 0.006
  10. Positivity of dengue and chikungunya among Crimean-Congo hemorrhagic fever-negative cases in India: 2013-2016. J Infect Public Health. 2018 Nov - Dec; 11(6):900-901.
    View in: PubMed
    Score: 0.006
  11. Circulation of Nipah virus in Pteropus giganteus bats in northeast region of India, 2015. Indian J Med Res. 2018 03; 147(3):318-320.
    View in: PubMed
    Score: 0.006
  12. Serosurvey of Malsoor virus among Rousettus leschenaulti bat & human population residing nearby Robber's cave, Mahabaleshwar, Maharashtra, India. Indian J Med Res. 2017 10; 146(4):545-547.
    View in: PubMed
    Score: 0.006
  13. Crimean-Congo Hemorrhagic Fever in Migrant Worker Returning from Oman to India, 2016. Emerg Infect Dis. 2017 06; 23(6):1005-1008.
    View in: PubMed
    Score: 0.006
  14. A mini-review of Bunyaviruses recorded in India. Indian J Med Res. 2017 May; 145(5):601-610.
    View in: PubMed
    Score: 0.006
  15. Difference in vector ticks dropping rhythm governs the epidemiology of Crimean-Congo haemorrhagic fever & Kyasanur forest disease in India. Indian J Med Res. 2016 Oct; 144(4):633-635.
    View in: PubMed
    Score: 0.005
  16. Re-occurrence of Crimean-Congo haemorrhagic fever in Ahmedabad, Gujarat, India (2012): a fatal case report. Indian J Med Res. 2013 Dec; 138(6):1027-8.
    View in: PubMed
    Score: 0.005
  17. Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.002
  18. Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.002
  19. Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays. J Med Virol. 2021 Dec; 93(12):6696-6702.
    View in: PubMed
    Score: 0.002
  20. Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021. J Infect. 2022 01; 84(1):94-118.
    View in: PubMed
    Score: 0.002
  21. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 01; 28(4).
    View in: PubMed
    Score: 0.002
  22. Electron microscopy imaging of SARS-CoV-2 at different temperatures. Indian J Med Res. 2021 05; 153(5&6):692-695.
    View in: PubMed
    Score: 0.002
  23. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 07; 21(7):950-961.
    View in: PubMed
    Score: 0.002
  24. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
    View in: PubMed
    Score: 0.002
  25. SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):190-195.
    View in: PubMed
    Score: 0.002
  26. Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):144-150.
    View in: PubMed
    Score: 0.002
  27. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):105-107.
    View in: PubMed
    Score: 0.002
  28. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):70-76.
    View in: PubMed
    Score: 0.002
  29. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):82-87.
    View in: PubMed
    Score: 0.002
  30. Identification of SARS-CoV-2 clusters from symptomatic cases in India. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):111-115.
    View in: PubMed
    Score: 0.002
  31. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):48-60.
    View in: PubMed
    Score: 0.002
  32. Respiratory virus detection among the overseas returnees during the early phase of COVID-19 pandemic in India. Indian J Med Res. 2020 05; 151(5):486-489.
    View in: PubMed
    Score: 0.002
  33. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May; 151(5):444-449.
    View in: PubMed
    Score: 0.002
  34. Authors' response. Indian J Med Res. 2020 05; 151(5):496.
    View in: PubMed
    Score: 0.002
  35. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):216-225.
    View in: PubMed
    Score: 0.002
  36. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):172-176.
    View in: PubMed
    Score: 0.002
  37. First isolation of SARS-CoV-2 from clinical samples in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):244-250.
    View in: PubMed
    Score: 0.002
  38. Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):255-260.
    View in: PubMed
    Score: 0.002
  39. Spatial Association Between a Nipah Virus Outbreak in India and Nipah Virus Infection in Pteropus Bats. Clin Infect Dis. 2019 07 02; 69(2):378-379.
    View in: PubMed
    Score: 0.002
  40. Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India. BMC Infect Dis. 2019 Feb 01; 19(1):104.
    View in: PubMed
    Score: 0.002
  41. Acute Encephalitis with Atypical Presentation of Rubella in Family Cluster, India. Emerg Infect Dis. 2018 10; 24(10):1923-1925.
    View in: PubMed
    Score: 0.002
  42. Molecular diversity of Coxsackievirus A10 circulating in the southern and northern region of India [2009-17]. Infect Genet Evol. 2018 12; 66:101-110.
    View in: PubMed
    Score: 0.002
  43. Characterization of Unknown Orthobunya-Like Viruses from India. Viruses. 2018 08 24; 10(9).
    View in: PubMed
    Score: 0.002
  44. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018 Aug; 148(2):145-150.
    View in: PubMed
    Score: 0.002
  45. Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016. Vector Borne Zoonotic Dis. 2018 03; 18(3):164-172.
    View in: PubMed
    Score: 0.002
  46. Experimental Zika virus infection in Aedes aegypti: Susceptibility, transmission & co-infection with dengue & chikungunya viruses. Indian J Med Res. 2018 Jan; 147(1):88-96.
    View in: PubMed
    Score: 0.001
  47. Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis. Future Microbiol. 2017 11; 12:1349-1362.
    View in: PubMed
    Score: 0.001
  48. First laboratory confirmation on the existence of Zika virus disease in India. J Infect. 2018 03; 76(3):314-317.
    View in: PubMed
    Score: 0.001
  49. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues. Indian J Med Res. 2017 10; 146(4):459-467.
    View in: PubMed
    Score: 0.001
  50. Retrospective analysis of clinical information in Crimean-Congo haemorrhagic fever patients: 2014-2015, India. Indian J Med Res. 2017 May; 145(5):673-678.
    View in: PubMed
    Score: 0.001
  51. Development of polymerase chain reaction-based diagnostic tests for detection of Malsoor virus & adenovirus isolated from Rousettus species of bats in Maharashtra, India. Indian J Med Res. 2017 Jan; 145(1):90-96.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.